In advanced-stage (stage III-IV) HCC patients, the levels of CD4+CD25+FOXP3+ Treg cells in the peripheral blood of those with large tumors were significantly higher than those with small tumors. This evidence concerns the gene CD4 and hepatocellular carcinoma.